Posted on 22/10/03
IR's uphill battle
The last couple of years have been hard on investors -- and even tougher on investor relations professionals. Just ask Peter McBride, vice-president of investor relations at Theratechnologies Inc., a Montreal prescription drug development company.
The full text of this article has 1239 words.
To continue reading this article, you will need to purchase this article.
This article is NOT available for licensing for re-use and redistribution.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
